UK markets open in 23 minutes

Anebulo Pharmaceuticals, Inc. (ANEB)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.95000.0000 (0.00%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-0.12-0.13-0.45-0.55
Low estimate-0.13-0.15-0.48-0.58
High estimate-0.11-0.11-0.43-0.52
Year ago EPS-0.11-0.1-0.47-0.45
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3332
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.16-0.11-0.12-0.1
Actual EPS-0.11-0.1-0.1-0.11
Difference0.050.010.02-0.01
Surprise %31.20%9.10%16.70%-10.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.12-0.13-0.45-0.55
7 days ago-0.12-0.13-0.45-0.55
30 days ago-0.12-0.13-0.45-0.55
60 days ago-0.12-0.13-0.45-0.55
90 days ago-0.1-0.1-0.4-0.61
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesANEBIndustrySector(s)S&P 500
Current qtr.-9.10%N/AN/AN/A
Next qtr.-30.00%N/AN/AN/A
Current year4.30%N/AN/AN/A
Next year-22.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A